| 7.59 0.05 (0.66%) | 07-18 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 9.23 | 1-year : | 10.14 |
| Resists | First : | 7.91 | Second : | 8.68 |
| Pivot price | 7.38  |
|||
| Supports | First : | 6.65 | Second : | 5.53 |
| MAs | MA(5) : | 7.49 |
MA(20) : | 7.46  |
| MA(100) : | 8.1 |
MA(250) : | 4.24 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 73.7 |
D(3) : | 67.1 |
| RSI | RSI(14): 49.7 |
|||
| 52-week | High : | 11.35 | Low : | 0.4 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ YI ] has closed below upper band by 22.0%. Bollinger Bands are 63.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 6 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 7.66 - 7.69 | 7.69 - 7.73 |
| Low: | 7.37 - 7.42 | 7.42 - 7.46 |
| Close: | 7.52 - 7.59 | 7.59 - 7.65 |
111, Inc. operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2B and B2C. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services that include online consultation services and electronic prescription services to consumers. It offers prescription and over-the counter drugs, including western and traditional Chinese medicines; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices comprising bandages and thermometers; and personal care products consisting of skin care, birth control, and sexual wellness products; and baby products. The company also operates an online marketplace where third-party sellers can directly sell to pharmacies; provides online loan application services to the clients of 1 Pharmacy, which include pharmacies and wholesalers; and data and supply chain integration services. As of December 31, 2021, it operated 14 offline retail pharmacies under the Yi Hao Pharmacy brand name in Guangzhou, Tianjin, Kunshan, Chongqing, and Wuhan provinces. In addition, the company offers warehousing, logistics, procurement, research and development, and consulting services; and software development and information technology support services. It serves pharmacies, pharmaceutical companies and distributors, medical professionals, and insurance companies. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2010 and is headquartered in Shanghai, the People's Republic of China.
Tue, 01 Jul 2025
(YI) Investment Analysis and Advice - news.stocktradersdaily.com
Fri, 20 Jun 2025
111 First Quarter 2025 Earnings: CN¥2.04 loss per share (vs CN¥1.61 loss in 1Q 2024) - Yahoo Finance
Thu, 19 Jun 2025
111 Inc Q1 Earnings Show Cost Efficiency Gains as Operating Expenses Shrink 30 Basis Points - Stock Titan
Thu, 20 Mar 2025
111 Inc Makes History: Turns First-Ever Profit as Operating Costs Plunge 470 Basis Points - Stock Titan
Wed, 12 Mar 2025
111 Inc CEO Reveals 2025 Growth Strategy: Exclusive Analyst Discussion on Q4 Performance - Stock Titan
Thu, 20 Feb 2025
111 to Announce Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results on March 20, 2025 - Conference Call to Follow - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Pharmaceuticals
|
|
| Shares Out | 5 (M) |
| Shares Float | 70 (M) |
| Held by Insiders | 15.8 (%) |
| Held by Institutions | 23.6 (%) |
| Shares Short | 1 (K) |
| Shares Short P.Month | 5 (K) |
| EPS | -2.18 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -75.82 |
| Profit Margin | -0.5 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -0.1 % |
| Return on Equity (ttm) | -7.8 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 84.75 |
| Sales Per Share | 2840.23 |
| EBITDA (p.s.) | 2.82 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 267 (M) |
| Levered Free Cash Flow | -168 (M) |
| PE Ratio | -3.5 |
| PEG Ratio | 0 |
| Price to Book value | -0.11 |
| Price to Sales | 0 |
| Price to Cash Flow | 0.14 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|